University of Michigan, Ann Arbor;
University of Rochester, Rochester, NY
Objective: To assess tumor markers in advanced laryngeal cancer.
Design: Marker expression and clinical outcome.
Patients: Tissues from 112 patients of the Veterans Affairs laryngeal cancer trial were analyzed: 42 from the chemotherapy arm and 70 from the surgical arm of the study.
Kumar B, Cordell KG, D'Silva N, Adams ME, Fisher SG, Wolf GT, Carey TE, Bradford CR. S024 Expression of p53 and Bcl-xL as Predictive Markers for Larynx Preservation in Advanced Laryngeal Cancer. Arch Otolaryngol Head Neck Surg. 2006;132(8):843-844. doi:10.1001/archotol.132.8.843-c